GlassScriptPhysician profile
Candace M Wada
NPI 1104830454
$4,574.23
in general payments reported to CMS, 2019-2025
10 companies · $1,224 in 2025
The $1,224 reported for 2025 was more than what 96% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,511 · 2020: $239 · 2021: $535 · 2022: $692 · 2023: $323 · 2024: $50.59 · 2025: $1,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $862 · Food and Beverage: $669 · Gift: $67.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $861.82 |
| Food and Beverage | $668.76 |
| Gift | $67.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $1,142.90 | 2021-2025 | |
| A-Dec, INC. | $1,116.00 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $827.47 | 2019-2021 | |
| Dentsply Sirona INC | $475.28 | 2019-2025 | Cerec, Cavitron, Vortex Blue Conform Fit |
| Zimvie INC. | $422.70 | 2022 | |
| Dentsply LLC | $250.00 | 2021 | |
| Dental Imaging Technologies Corp. | $187.11 | 2022 | |
| Straumann USA LLC | $121.55 | 2019-2023 | |
| Biolase, INC. | $17.58 | 2019 | |
| Colgate Oral Pharmaceuticals, INC. | $13.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candace Wada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.